iRhythm Technologies (NASDAQ:IRTC – Get Free Report) Director Abhijit Talwalkar acquired 7,900 shares of iRhythm Technologies stock in a transaction on Thursday, November 19th. The stock was purchased at an average cost of $96.67 per share, for a total transaction of $763,693.00. Following the purchase, the director owned 7,900 shares in the company, valued at approximately $763,693. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
iRhythm Technologies Stock Up 0.5%
Shares of NASDAQ IRTC opened at $94.72 on Friday. The company has a market cap of $3.18 billion, a P/E ratio of -80.96 and a beta of 1.39. The firm has a 50-day simple moving average of $109.28 and a two-hundred day simple moving average of $118.36. iRhythm Technologies has a 1 year low of $82.85 and a 1 year high of $192.47. The company has a debt-to-equity ratio of 3.68, a current ratio of 3.57 and a quick ratio of 3.45.
iRhythm Technologies (NASDAQ:IRTC – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $0.82 EPS for the quarter, topping the consensus estimate of $0.02 by $0.80. iRhythm Technologies had a positive return on equity of 26.88% and a negative net margin of 4.52%. The firm had revenue of $221.59 million during the quarter, compared to analyst estimates of $222.23 million. During the same period in the previous year, the company posted ($0.06) EPS. The business’s revenue for the quarter was up 14.9% compared to the same quarter last year. Research analysts anticipate that iRhythm Technologies will post 0.79 earnings per share for the current year.
iRhythm Technologies announced that its Board of Directors has initiated a share repurchase program on Wednesday, November 11th that authorizes the company to repurchase $200 million in shares. This repurchase authorization authorizes the company to purchase up to 6.7% of its stock through open market purchases. Share repurchase programs are typically a sign that the company’s management believes its shares are undervalued.
Analyst Ratings Changes
IRTC has been the subject of several research reports. Stephens reduced their target price on iRhythm Technologies from $160.00 to $120.00 and set an “overweight” rating for the company in a report on Wednesday, November 11th. Wells Fargo & Company dropped their target price on iRhythm Technologies from $150.00 to $135.00 and set an “overweight” rating for the company in a research note on Friday, November 6th. BTIG Research lowered their price target on iRhythm Technologies from $185.00 to $170.00 and set a “buy” rating for the company in a report on Friday, November 6th. Truist Financial dropped their price target on shares of iRhythm Technologies from $168.00 to $140.00 and set a “buy” rating for the company in a research note on Monday, November 9th. Finally, Canaccord Genuity Group increased their price target on iRhythm Technologies from $196.00 to $206.00 and gave the stock a “buy” rating in a research report on Friday, November 6th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, iRhythm Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $164.07.
Get Our Latest Report on iRhythm Technologies
Institutional Investors Weigh In On iRhythm Technologies
Several large investors have recently made changes to their positions in IRTC. Stephens Investment Management Group LLC grew its position in shares of iRhythm Technologies by 1.7% in the 3rd quarter. Stephens Investment Management Group LLC now owns 705,533 shares of the company’s stock valued at $80,191,000 after acquiring an additional 12,096 shares during the period. Braidwell LP grew its stake in shares of iRhythm Technologies by 7.2% in the second quarter. Braidwell LP now owns 654,262 shares of the company’s stock worth $77,824,000 after purchasing an additional 44,070 shares during the last quarter. The Manufacturers Life Insurance Company lifted its stake in shares of iRhythm Technologies by 99.2% in the 1st quarter. The Manufacturers Life Insurance Company now owns 390,577 shares of the company’s stock valued at $46,096,000 after purchasing an additional 194,502 shares during the period. Rock Springs Capital Management LP increased its holdings in shares of iRhythm Technologies by 11.4% during the first quarter. Rock Springs Capital Management LP now owns 261,750 shares of the company’s stock valued at $30,892,000 after acquiring an additional 26,750 shares in the last quarter. Finally, Voya Investment Management LLC boosted its stake in shares of iRhythm Technologies by 3,578.5% in the 3rd quarter. Voya Investment Management LLC now owns 230,934 shares of the company’s stock worth $26,248,000 after buying an additional 224,656 shares during the last quarter.
About iRhythm Technologies
iRhythm Technologies is a medical technology company that develops digital solutions for detecting and monitoring heart rhythm disorders. Its services combine wearable electrocardiogram (ECG) devices with cloud-based data analysis and clinical reporting to help healthcare professionals assess patients for conditions such as cardiac arrhythmias. The company’s Zio product line includes wearable ECG monitors, such as Zio XT, which records a patient’s heart activity during an extended monitoring period. iRhythm also offers Zio AT, a monitoring service designed to provide clinicians with ECG data during the monitoring period.
Recommended Stories
- Five stocks we like better than iRhythm Technologies
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
